Treatment for Anxiety in Adults
For generalized anxiety disorder in adults, start with either an SSRI (such as sertraline) or cognitive behavioral therapy (CBT) as first-line treatment, with the choice based on patient preference, symptom severity, and access to care.
Pharmacotherapy Approach
First-Line Medications
SSRIs and SNRIs are the recommended first-line pharmacological treatments for anxiety disorders including generalized anxiety disorder, panic disorder, and social anxiety disorder 1, 2. These medications demonstrate:
- Small to medium effect sizes compared to placebo (standardized mean difference -0.55 for GAD, -0.67 for social anxiety disorder) 2
- Good tolerability without considerable long-term adverse effects 3
- Efficacy rates between 60-85% 4
Specific SSRI options include:
- Sertraline
- Other SSRIs as appropriate
SNRI option:
Medications to Avoid
Benzodiazepines are NOT recommended for first-line therapy or long-term use due to:
They may only be considered short-term while awaiting effect of daily medication 3.
Psychotherapy Approach
First-Line Psychotherapy
Cognitive behavioral therapy (CBT) is the psychotherapy with the strongest evidence for anxiety disorders 1, 2. The evidence shows:
- Large effect size for GAD (Hedges g = 1.01) 2
- Small to medium effect sizes for social anxiety disorder and panic disorder 2
- Comparable efficacy to pharmacotherapy
For social anxiety disorder specifically, individual CBT sessions following the Clark and Wells model or Heimberg model are prioritized over group therapy due to superior clinical and cost-effectiveness 1.
Alternative Psychotherapy Options
If patients decline face-to-face CBT:
- Self-help with CBT support is an acceptable alternative 1
- Internet and mobile-based CBT interventions have comparable efficacy to face-to-face therapy 6, 3
Other psychological therapies (mindfulness-based intervention, acceptance and commitment therapy, psychodynamic therapy) have been tried but have not proven superior to CBT 6.
Treatment Selection Algorithm
Step 1: Initial Assessment
- Screen using validated tools (GAD-7 has sensitivity 57.6-93.9%, specificity 61-97%) 2
- Rule out substance use disorders (treat concurrently if present) 5
- Assess for medical conditions causing somatic symptoms
Step 2: Determine Symptom Severity
- Subthreshold symptoms or adjustment-related anxiety: Start with self-help and behavioral interventions 3
- Full anxiety disorder diagnosis: Proceed to Step 3
Step 3: Choose Initial Treatment Based On:
Choose CBT if:
- Patient prefers non-medication approach
- Access to skilled CBT therapist available
- No urgent need for rapid symptom control
- Brief CBT (6-12 sessions) can be delivered in primary care by embedded behavioral health clinicians 3
Choose SSRI/SNRI if:
- Patient prefers medication
- Limited access to CBT
- Severe symptoms requiring faster intervention
- Previous positive response to medication
Consider combined treatment if:
- Severe symptoms
- Partial response to monotherapy
- Patient preference
- Note: Guidelines show no strong recommendation for routine combination therapy over monotherapy 1
Step 4: Second-Line Options (if first-line fails)
For pharmacotherapy:
Important Clinical Considerations
Common Pitfalls to Avoid
- Do not prescribe benzodiazepines long-term - they increase mortality and dependence risk
- Do not assume combination therapy is always better - evidence does not support routine combination of medication and psychotherapy over monotherapy 1
- Do not overlook substance use disorders - these must be treated concurrently
Monitoring and Follow-up
- Reassess symptoms regularly using standardized measures
- SSRIs/SNRIs typically require 4-6 weeks for full effect
- CBT typically delivered over 6-12 sessions in primary care settings
Special Populations
- Pediatric patients: SSRIs remain first-line, with psychotherapy enhancing response 7
- Geriatric patients: First-line treatments remain the same but require dose adjustments 4
- Pregnant/planning pregnancy: Requires careful risk-benefit discussion
Collaborative Care Model
The Collaborative Care Management model improves outcomes compared to usual primary care 3. This involves:
- Primary care clinician prescribing
- Consulting psychiatrist available
- Care manager monitoring progress and providing behavioral treatment
This model is particularly effective when embedded behavioral health clinicians can deliver brief CBT directly in primary care settings 3.